Loading…
Based on limited metadata, this FDA Warning Letter issued to Infusion Partners, LLC on March 20, 2019, concerns drug products, though the specific nature of the violations cannot be determined without access to the full letter text. The warning falls under FDA's drug regulation authority, but the issuing office and detailed violation count are not available in the metadata provided. To understand the specific compliance issues and required corrective actions, the complete warning letter would need to be reviewed.